Philip Kuebler

4.1k total citations · 3 hit papers
19 papers, 2.8k citations indexed

About

Philip Kuebler is a scholar working on Oncology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Philip Kuebler has authored 19 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 5 papers in Physiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Philip Kuebler's work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer survivorship and care (4 papers). Philip Kuebler is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer survivorship and care (4 papers). Philip Kuebler collaborates with scholars based in United States, Canada and Germany. Philip Kuebler's co-authors include Wendy L. Frankel, Dan Fix, Jenny Panescu, Judith A. Westman, Thomas W. Prior, Ilene Comeras, K. S. Khanduja, Edward W. Martin, Kaisa Sotamaa and Albert de la Chapelle and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Philip Kuebler

18 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)

2005 973 citations Heather Hampel, Wendy L. Frankel et al. New England Journal of Medicine profile →
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

1992 752 citations Patrick J. Loehrer, Lawrence H. Einhorn et al. Journal of Clinical Oncology profile →
Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer

2008 612 citations Heather Hampel, Wendy L. Frankel et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Philip Kuebler

Since Specialization

Citations

This map shows the geographic impact of Philip Kuebler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Kuebler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Kuebler more than expected).

Fields of papers citing papers by Philip Kuebler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Kuebler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Kuebler. The network helps show where Philip Kuebler may publish in the future.

Co-authorship network of co-authors of Philip Kuebler

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Kuebler. A scholar is included among the top collaborators of Philip Kuebler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Kuebler. Philip Kuebler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B–Southwest Oncology Group 80702 (Alliance) 2024 ·JNCI Journal of the National Cancer Institute ·Justin C. Brown, (unknown), Qian Shi, Félix Couture, Philip Kuebler, Pankaj Kumar, Benjamin Tan, Smitha Krishnamurthi, Victor T. Chang, Richard M. Goldberg, Eileen M. O’Reilly, Anthony F. Shields, Jeffrey A. Meyerhardt	1
2	Association between physical activity and the time course of cancer recurrence in stage III colon cancer 2023 ·British Journal of Sports Medicine ·Justin C. Brown, (unknown), Qian Shi, Donna Niedzwiecki, Tyler Zemla, Félix Couture, Philip Kuebler, Pankaj Kumar, Judith O. Hopkins, Benjamin Kye Jyn Tan, Smitha Krishnamurthi, Eileen M. O’Reilly, Anthony F. Shields, Jeffrey A. Meyerhardt	19
3	Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance) 2023 ·Cancer ·Justin C. Brown, (unknown), Qian Shi, Tyler Zemla, Félix Couture, Philip Kuebler, Pankaj Kumar, Benjamin Tan, Smitha Krishnamurthi, Victor T. Chang, Richard M. Goldberg, Alan P. Venook, Charles D. Blanke, Eileen M. O’Reilly, Anthony F. Shields, Jeffrey A. Meyerhardt	2
4	Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer 2023 ·JAMA Oncology ·En Cheng, Qian Shi, Anthony F. Shields, Andrew B. Nixon, Ardaman Shergill, (unknown), Katherine A. Guthrie, Félix Couture, Philip Kuebler, Pankaj Kumar, Benjamin Kye Jyn Tan, Smitha Krishnamurthi, Kimmie Ng, Eileen M. O’Reilly, Justin C. Brown, Philip A. Philip, Bette J. Caan, Elizabeth M. Cespedes Feliciano, Jeffrey A. Meyerhardt	25
5	Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance) 2023 ·British Journal of Cancer ·Seohyuk Lee, (unknown), Qian Shi, Jeffrey P. Meyers, Pankaj Kumar, Félix Couture, Philip Kuebler, Smitha Krishnamurthi, DeQuincy Andrew Lewis, Benjamin Tan, Eileen M. O’Reilly, Anthony F. Shields, Jeffrey A. Meyerhardt	8
6	Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702 2022 ·Journal of Clinical Oncology ·Seohyuk Lee, (unknown), Qian Shi, Pankaj Kumar, Félix Couture, Philip Kuebler, Smitha Krishnamurthi, DeQuincy Andrew Lewis, Benjamin Kye Jyn Tan, Richard M. Goldberg, Alan P. Venook, Charles D. Blanke, Eileen M. O’Reilly, Anthony F. Shields, Jeffrey A. Meyerhardt	10
7	Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance) 2022 ·Journal of Clinical Oncology ·Justin C. Brown, (unknown), Qian Shi, Charles S. Fuchs, (unknown), Donna Niedzwiecki, Tyler Zemla, Félix Couture, Philip Kuebler, Pankaj Kumar, DeQuincy Andrew Lewis, Benjamin Kye Jyn Tan, Smitha Krishnamurthi, Eileen M. O’Reilly, Anthony F. Shields, Jeffrey A. Meyerhardt	24
8	Abstract 682: Associations of inflammatory biomarkers with survival among patients with stage III colon cancer (CALGB/SWOG 80702 [Alliance]) 2022 ·Cancer Research ·En Cheng, Qian Shi, Anthony F. Shields, Elizabeth M. Cespedes Feliciano, Andrew B. Nixon, Ardaman Shergill, Katherine A. Guthrie, Félix Couture, Philip Kuebler, Pankaj Kumar, DeQuincy Andrew Lewis, Benjamin Tan, Eileen M. O’Reilly, Justin C. Brown, Philip A. Philip, Bette J. Caan, Jeffrey A. Meyerhardt	0
9	Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)☆ 2021 ·Annals of Oncology ·Romain Cohen, Qian Shi, (unknown), Zhe Jin, Magali Svrcek, Charles S. Fuchs, Félix Couture, Philip Kuebler, Kristen K. Ciombor, Johanna C. Bendell, Ana De Jesus‐Acosta, Pankaj Kumar, DeQuincy Andrew Lewis, Benjamin Kye Jyn Tan, Monica M. Bertagnolli, (unknown), Charles D. Blanke, Eileen M. O’Reilly, (unknown), Jeffrey A. Meyerhardt	66
10	Race/Ethnicity-Based Concerns Over Understanding Cancer Diagnosis and Treatment Plan 2010 ·Journal of the National Medical Association ·Pascal Jean‐Pierre, Kevin Fiscella, Jennifer J. Griggs, Jean Joseph, Gary R. Morrow, Jennifer K. Carroll, Samantha Hendren, Jason Q. Purnell, Colmar Figueroa-Moseley, Philip Kuebler, Tarit K. Banerjee, Jeffrey J. Kirshner	34
11	Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions 2008 ·European Heart Journal ·M. Ferenc, Michael Gick, Rolf-Peter Kienzle, Hans-Peter Bestehorn, (unknown), Thomas Comberg, Philip Kuebler, Heinz‐Joachim Büttner, Franz-Joseph Neumann	219
12	Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer breakdown → 2008 ·Journal of Clinical Oncology ·Heather Hampel, Wendy L. Frankel, Edward W. Martin, Mark Arnold, K. S. Khanduja, Philip Kuebler, Mark Clendenning, Kaisa Sotamaa, Thomas W. Prior, Judith A. Westman, Jenny Panescu, Dan Fix, Janet Lockman, (unknown), Ilene Comeras, Albert de la Chapelle	612
13	Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) breakdown → 2005 ·New England Journal of Medicine ·Heather Hampel, Wendy L. Frankel, Edward W. Martin, Mark Arnold, K. S. Khanduja, Philip Kuebler, Hidewaki Nakagawa, Kaisa Sotamaa, Thomas W. Prior, Judith A. Westman, Jenny Panescu, Dan Fix, Janet Lockman, Ilene Comeras, Albert de la Chapelle	973
14	Patient expectation is a strong predictor of severe nausea after chemotherapy 2004 ·Cancer ·Joseph A. Roscoe, Peter Bushunow, Gary R. Morrow, Jane T. Hickok, Philip Kuebler, Andrew Jacobs, Tarit K. Banerjee	72
15	Smoking status affects chemotherapy-induced neutropenia 2004 ·Journal of Clinical Oncology ·Leslie R. Laufman, H. Spiridonidis, (unknown), Lindsay B. Baker, Philip Kuebler, David J. Young	2
16	Smoking status affects chemotherapy-induced neutropenia 2004 ·Journal of Clinical Oncology ·Leslie R. Laufman, H. Spiridonidis, (unknown), (unknown), Philip Kuebler, (unknown)	1
17	A preliminary report of a double blind placebo controlled trial of gabapentin for control of hot flashes in women with breast cancer. A University of Rochester Cancer Center CCOP study 2004 ·Journal of Clinical Oncology ·K. J. Pandya, Joseph A. Roscoe, Eduardo R. Pajon, Philip Kuebler, (unknown), P. Flynn, Jane T. Hickok, Gary R. Morrow	4
18	Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study 1998 ·Investigational New Drugs ·Wolfram E. Samlowski, Danika L. Lew, Philip Kuebler, Michael Kolodziej, Jesús E. Medina, Kenneth F. Mangan, (unknown), (unknown), John F. Ensley	6
19	A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. breakdown → 1992 ·Journal of Clinical Oncology ·Patrick J. Loehrer, Lawrence H. Einhorn, Paul Elson, Emily Crawford, Philip Kuebler, Ian F. Tannock, Derek Raghavan, R. Stuart‐Harris, Michael F. Sarosdy, B A Lowe	752

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact